Plexus (PLXS) Reports Q2 Earnings: What Key Metrics Have to Say

24.04.25 01:30 Uhr

Werte in diesem Artikel
Aktien

110,00 EUR -1,00 EUR -0,90%

69,50 EUR 2,00 EUR 2,96%

For the quarter ended March 2025, Plexus (PLXS) reported revenue of $980.17 million, up 1.4% over the same period last year. EPS came in at $1.66, compared to $0.94 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $980.47 million, representing a surprise of -0.03%. The company delivered an EPS surprise of +7.79%, with the consensus EPS estimate being $1.54.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Market Sector- Healthcare/Life Sciences: $411 million versus the two-analyst average estimate of $407.10 million. The reported number represents a year-over-year change of +8.4%. Revenue- Market Sector- Aerospace/Defense: $172 million versus $174.10 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +1.2% change. Revenue- Market Sector- Industrial: $397 million versus $399.55 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5% change. View all Key Company Metrics for Plexus here>>>Shares of Plexus have returned -6.1% over the past month versus the Zacks S&P 500 composite's -6.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Plexus Corp. (PLXS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Plexus und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Plexus

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Plexus

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Plexus Corp.

Wer­bung

Analysen zu Plexus Corp.

DatumRatingAnalyst
23.04.2019Plexus BuyNeedham & Company, LLC
20.01.2017Plexus Sector PerformRBC Capital Markets
22.04.2016Plexus BuyNeedham & Company, LLC
22.04.2016Plexus Sector PerformRBC Capital Markets
13.10.2015Plexus Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.04.2019Plexus BuyNeedham & Company, LLC
22.04.2016Plexus BuyNeedham & Company, LLC
24.07.2015Plexus Strong BuyNeedham & Company, LLC
24.04.2015Plexus Strong BuyNeedham & Company, LLC
16.12.2014Plexus Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
20.01.2017Plexus Sector PerformRBC Capital Markets
22.04.2016Plexus Sector PerformRBC Capital Markets
13.10.2015Plexus Sector PerformRBC Capital Markets
09.11.2012Plexus sector performRBC Capital Markets
22.07.2011Plexus sector performRBC Capital Markets
DatumRatingAnalyst
09.01.2006Update Plexus Corp.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Plexus Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen